Phyto Chem India Ltd

Q1 FY27 standalone results

• Revenue from operations: Rs 2.54 lakh; total income: Rs 6.08 lakh in Q1 FY27.
• Profit before tax: Rs -93.39 lakh; tax expense: Rs -2.92 lakh; net loss Rs -90.47 lakh.
• EPS (basic and diluted): Rs -2.10 for Q1 FY27.
• Board approved unaudited results; limited review by Yelamanchi & Associates dated 13 Aug 2026.

Dematerialisation status

• Dematerialisation requests processed; certificates mutilated and cancelled after verification.
• Depository name updated as registered owner within prescribed timeline.
• Dematerialised securities listed on the stock exchanges where the earlier issued securities are listed.

Phyto Chem India Ltd — Trading Window closed from 1 July 2026 to 48 hours after declaration of Q1 FY 2026-27 unaudited financial results for the quarter ended June 30, 2026.

Results

• 📊 Q4 FY26 revenue from operations was ₹231.5 lakh, versus ₹145.5 lakh a year earlier.
• 📊 FY26 revenue from operations was ₹907.05 lakh, down from ₹1,407.84 lakh in FY25.
• 📊 Q4 FY26 total income was ₹105.01 lakh; FY26 total income was ₹1,090.25 lakh.
• 📊 FY26 total expenses were ₹1,277.54 lakh, led by raw materials, finance costs, and employee expenses.
• 📊 Q4 FY26 loss before tax was ₹28.17 lakh; FY26 loss before tax was ₹187.29 lakh.
• 📊 Q4 FY26 net loss was ₹27.63 lakh; FY26 net loss was ₹180.28 lakh.
• 📊 FY26 basic and diluted EPS were both negative ₹4.19.
• 📊 Other comprehensive loss was ₹1.54 lakh in FY26.

Business metrics

• 📊 Raw material consumption was ₹808.92 lakh in FY26, down from ₹1,049.06 lakh.
• 📊 Employee benefits expense was ₹137.18 lakh in FY26, versus ₹211.49 lakh in FY25.
• 📊 Finance costs were ₹150.17 lakh in FY26, down from ₹184.00 lakh.
• 📊 Trade receivables rose to ₹1,639.10 lakh from ₹1,424.64 lakh.
• 📊 Inventories fell to ₹827.84 lakh from ₹1,009.84 lakh.
• 📊 Cash and cash equivalents closed at ₹2.37 lakh, versus ₹4.61 lakh last year.
• 📊 Current borrowings increased to ₹2,041.90 lakh from ₹1,491.27 lakh.

Cash flow

• 📊 Net cash from operating activities was ₹91.43 lakh in FY26, versus ₹176.93 lakh in FY25.
• 📊 Net cash from investing activities was ₹162.15 lakh in FY26.
• 📊 Net cash used in financing activities was ₹255.82 lakh in FY26.
• 📊 Closing cash and cash equivalents were ₹2.37 lakh at 31 March 2026.

Board actions

• 📍 The Board approved audited financial results for Q4 and FY26 on 29 May 2026.
• 📍 The company filed a claim of ₹6,21,84,043.42 against Siri Smelters & Energy Private Limited.
• 📍 The claim was filed as an operational creditor before the IRP on 25 May 2026.
• 📍 Claim admission or reconciliation is under process.

Audit

• 📍 Statutory auditors issued an unmodified opinion on the audited standalone financial results.
• 📍 The report states the results give a true and fair view under applicable accounting standards.

Guidance and risks

• ⚠️ The company operates mainly in manufacturing and marketing of pesticide formulations.
• ⚠️ Deferred tax expense was negative ₹7.01 lakh in FY26 under the 115BAA tax option.

Business model

• Phyto Chem (India) Limited manufactures and markets pesticide formulations.
• The company reports as a single operating segment.
• The results are standalone audited financial results for Q4 and FY26.